<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="111762">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01648959</url>
  </required_header>
  <id_info>
    <org_study_id>12-0268-B</org_study_id>
    <nct_id>NCT01648959</nct_id>
  </id_info>
  <brief_title>Intra Cranial EEG Activity During Dexmedetomidine Sedation</brief_title>
  <official_title>Intra Cranial EEG Activity During Dexmedetomidine Sedation.Comparing the Effects of Dexmedetomidine on the Cortical and the Sub Cortical(Hippocampus) Structures.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Health Network, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Health Network, Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Various parts of the brain are sensitive to various anesthetics.We like to study the effect
      of dexmedetomidine on the different parts of the brain in patients who are coming for DBS
      electrode removal under sedation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cortical and sub cortical structures will have different sensitivities to various
      anesthetics.The objective of this study is to look at the changes in the intracranial
      electroencephalographic (EEG) characteristics during dexmedetomidine sedation and to
      determine the differences in the EEG characteristics between cortical and subcortical
      structures.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Lack of funding
  </why_stopped>
  <start_date>July 2012</start_date>
  <completion_date type="Actual">March 2014</completion_date>
  <primary_completion_date type="Actual">March 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>EEG Recording</measure>
    <time_frame>1 day</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">20</enrollment>
  <condition>EEG Effect of Dexmedetomidine on the Cortical and Subcortical Structures</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>EEG Recording</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adults between 18 to 80 years of age, who are scheduled for elective removal of
        intracranial (surface and depth) electrodes under conscious sedation
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults between 18 to 80 years of age, who are scheduled for elective removal of
             intracranial (surface and depth) electrodes under conscious sedation

        Exclusion Criteria:

          -  Lack of informed consent

          -  Hypersensitivity to dexmedetomidine

          -  Language barrier

          -  Emergency surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>lashmikumar venkatraghavan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistant professor,Toronto western hospital,university health network (UHN)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Toronto Western Hospital,UHN.</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5T2S8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>February 2015</verification_date>
  <lastchanged_date>February 9, 2015</lastchanged_date>
  <firstreceived_date>July 13, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
